Comparative Evaluation of Risk Assessment Models for Predicting Venous Thromboembolic Events in Cancer Patients with Implanted Central Venous Access Devices
Cancer patients with ICVADs face a substantial risk of early VTEs. Among evaluated RAMs, ONKOTEV performed best for overall but not ICVAD-related events. Prospective studies are needed to guide prophylaxis strategies using validated RAMs.
Authors
- Anas Zayed
- Maryam El-Atrash
- Hikmat Abdel‐Razeq (ORCID: https://orcid.org/0000-0003-2833-6051)
- Mohammed Al‐Jaghbeer (ORCID: https://orcid.org/0009-0001-4832-2960)
- Mohammad Alshobaki
- Renad Hamdan-Mansour
- Mohammad Ma’koseh
- Heba Farfoura
- Zaid Abdel Rahman (ORCID: https://orcid.org/0000-0003-2959-1177)
- Tala Ghatasheh
- Mahmoud Abunasser
Institutions
- University of Jordan (JO)
- King Hussein Cancer Center (JO)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-14
- DOI
- https://doi.org/10.3390/cancers17203308
- Primary Topic
- Venous Thromboembolism Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00